| Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source SM McKiernan, R Hagan, M Curry, GSA McDonald, A Kelly, N Nolan, ... Hepatology 40 (1), 108-114, 2004 | 341 | 2004 |
| CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons AJ MacDonald, M Duffy, MT Brady, S McKiernan, W Hall, J Hegarty, ... The Journal of infectious diseases 185 (6), 720-727, 2002 | 339 | 2002 |
| Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution C Neumann‐Haefelin, S McKiernan, S Ward, S Viazov, HC Spangenberg, ... Hepatology 43 (3), 563-572, 2006 | 262 | 2006 |
| Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration D Swan, J Long, O Carr, J Flanagan, H Irish, S Keating, M Keaveney, ... AIDS patient care and STDs 24 (12), 753-762, 2010 | 247 | 2010 |
| Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection MM Dring, MH Morrison, BP McSharry, KJ Guinan, R Hagan, ... Proceedings of the National Academy of Sciences 108 (14), 5736-5741, 2011 | 162 | 2011 |
| Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response E Dazert, C Neumann-Haefelin, S Bressanelli, K Fitzmaurice, J Kort, ... The Journal of clinical investigation 119 (2), 376-386, 2009 | 153 | 2009 |
| The CCR5-Δ32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source C Goulding, A Murphy, G MacDonald, S Barrett, J Crowe, J Hegarty, ... Gut 54 (8), 1157-1161, 2005 | 135 | 2005 |
| Molecular footprints reveal the impact of the protective HLA-A* 03 allele in hepatitis C virus infection K Fitzmaurice, D Petrovic, N Ramamurthy, R Simmons, S Merani, ... Gut 60 (11), 1563-1571, 2011 | 99 | 2011 |
| Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak S Merani, D Petrovic, I James, A Chopra, D Cooper, E Freitas, A Rauch, ... Hepatology 53 (2), 396-405, 2011 | 75 | 2011 |
| Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype‐specific immunodominant CD8+ T‐cell epitope C Neumann‐Haefelin, J Timm, J Schmidt, N Kersting, K Fitzmaurice, ... Hepatology 51 (1), 54-62, 2010 | 72 | 2010 |
| The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C SM McKiernan, R Hagan, M Curry, GSA McDonald, N Nolan, J Crowley, ... Gastroenterology 118 (6), 1124-1130, 2000 | 62 | 2000 |
| Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including variceal and nonvariceal haemorrhage C Lahiff, W Shields, I Cretu, N Mahmud, S McKiernan, S Norris, B Silke, ... European journal of gastroenterology & hepatology 24 (2), 149-154, 2012 | 58 | 2012 |
| Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic … O Elsherif, C Bannan, S Keating, S McKiernan, C Bergin, S Norris PLoS One 12 (6), e0178398, 2017 | 39 | 2017 |
| The diagnostic accuracy of endoscopic ultrasound in suspected biliary obstruction and its impact on endoscopic retrograde cholangiopancreatography burden in real clinical … A Zaheer, MM Anwar, C Donohoe, S O’Keeffe, H Mushtaq, B Kelleher, ... European journal of gastroenterology & hepatology 25 (7), 850-857, 2013 | 32 | 2013 |
| Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study JA Kieran, S Norris, A O’Leary, C Walsh, R Merriman, D Houlihan, ... BMC infectious diseases 15, 1-9, 2015 | 30 | 2015 |
| Evaluating peer-supported screening as a hepatitis C case-finding model in prisoners D Crowley, R Murtagh, W Cullen, M Keevans, E Laird, T McHugh, ... Harm Reduction Journal 16, 1-10, 2019 | 28 | 2019 |
| Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease … M Duffy, M Salemi, N Sheehy, AM Vandamme, J Hegarty, M Curry, ... Virology 301 (2), 354-364, 2002 | 28 | 2002 |
| The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017 D Crowley, JS Lambert, G Betts-Symonds, W Cullen, M Keevans, E Kelly, ... Eurosurveillance 24 (14), 1800369, 2019 | 23 | 2019 |
| Chronic hepatitis C infection and sicca syndrome: a clear association with HLA DQB1* 02 CM Smyth, SM McKiernan, R Hagan, R Pilkington, M O'Regan, E Lawlor, ... European journal of gastroenterology & hepatology 19 (6), 493-498, 2007 | 23 | 2007 |
| Primary cutaneous B-cell lymphoma: an association of chronic hepatitis C infection S McKiernan, R Pilkington, B Ramsay, A Walsh, E Sweeney, D Kelleher European journal of gastroenterology & hepatology 11 (6), 669-672, 1999 | 20 | 1999 |
